361 related articles for article (PubMed ID: 26307627)
1. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?
Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H
Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627
[TBL] [Abstract][Full Text] [Related]
2. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
3. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
Mai SK; Welzel G; Hermann B; Wenz F; Haberkorn U; Dinter DJ
Strahlenther Onkol; 2009 Apr; 185(4):254-9. PubMed ID: 19370429
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a 36 Gy elective node irradiation dose in anal cancer.
Lépinoy A; Lescut N; Puyraveau M; Caubet M; Boustani J; Lakkis Z; Fantoli M; Buffet-Miny J; Kim S; Bednarek C; Maingon P; Créhange G; Bosset JF
Radiother Oncol; 2015 Aug; 116(2):197-201. PubMed ID: 26277433
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
6. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.
Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L
J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657
[TBL] [Abstract][Full Text] [Related]
7. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
[TBL] [Abstract][Full Text] [Related]
8. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation?
Crowley C; Winship AZ; Hawkins MA; Morris SL; Leslie MD
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):376-9. PubMed ID: 19282157
[TBL] [Abstract][Full Text] [Related]
9. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
12. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma.
Blinde SE; Schasfoort R; Mens JW; Verhoef C; Olofsen M; Nuyttens JJ
Dis Colon Rectum; 2014 May; 57(5):578-84. PubMed ID: 24819097
[TBL] [Abstract][Full Text] [Related]
13. Clinical target volumes in anal cancer: calculating what dose was likely to have been delivered in the UK ACT II trial protocol.
Aggarwal A; Gayadeen S; Robinson D; Hoskin PJ; Mawdsley S; Harrison M; Hughes R; Glynne-Jones R
Radiother Oncol; 2012 Jun; 103(3):341-6. PubMed ID: 22521502
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
[TBL] [Abstract][Full Text] [Related]
15. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
16. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy.
Rosenzweig KE; Sim SE; Mychalczak B; Braban LE; Schindelheim R; Leibel SA
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):681-5. PubMed ID: 11395236
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
18. Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.
Ugurluer G; Ballerini G; Moeckli R; Matzinger O; Bourhis J; Ozsahin M
Tumori; 2015; 101(3):268-72. PubMed ID: 25908035
[TBL] [Abstract][Full Text] [Related]
19. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
Zilli T; Betz M; Bieri S; Ris F; Roche B; Roth AD; Allal AS
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):60-6. PubMed ID: 23608237
[TBL] [Abstract][Full Text] [Related]
20. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]